Abstract:Combining photodynamic therapy (PDT), chemodynamic therapy (CDT), and ferroptosis is a valuable means for an enhanced anticancer effect. However, traditional combination of PDT/CDT/ferroptosis faces several hurdles, including excess glutathione (GSH) neutralization and preparation complexity. In this work, a versatile multifunctional nanoparticle (HCNP) self-assembled from two porphyrin molecules, chlorin e6 and hemin, is developed. The as-constructed HCNPs exhibit a peroxidase-mimic catalytic activity, which can lead to the in situ generation of endogenous O2, thereby enhancing the efficacy of PDT. Furthermore, the generation of hydroxyl radicals (•OH) in the tumor environment in reaction to the high level of H2O2 and the simultaneous disruption of intracellular GSH endow the HCNPs with the capacity of enhanced CDT, resulting in a more effective therapeutic outcome in combination with PDT. More importantly, GSH depletion further leads to the inactivation of GSH peroxide 4 and induced ferroptosis. Both in vitro and in vivo results showed that the combination of PDT/CDT/ferroptosis realizes highest antitumor efficacy significantly under laser irradiation. Therefore, by integrating the superiorities of O2 and •OH generation capacity, GSH-depletion effect, and bioimaging into a single nanosystem, the HCNPs are a promising single therapeutic agent for tumor PDT/CDT/ferroptosis combination therapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c04868?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c04868</a>.DLS size profile of HCNPs with different precursor molar concentration ratios; ζ potential and XPS spectra of HCNPs; fluorescence spectra of free Ce6 and HCNPs in different media; the photostability of HCNPs; UV–vis absorption spectra of MB degradation by different concentrations of hemin; photographs of HCNP solutions with H2O2; 1O2 generation of HCNPs with or without H2O2; photothermal effect of HCNPs; the detection of Fe2+ of HCNPs with different concentrations of GSH; DLS size profile of HCNPs after incubation with 10 mM GSH; stability of HCNPs; MD simulation; the UV spectrum of HCNPs in different buffer solutions; the cell uptake and intracellular location of HCNPs; Western blot analysis of GPX4 in 4T1 cells after treatment with PBS, Ce6, and hemin; determination of ROS in 4T1 cells by flow cytometry analysis; live/dead cell assay for cells treated with PBS, Ce6, hemin, and HCNPs in different conditions; cell viability of 4T1 cells treated with different concentrations of Ce6 or hemin; schematic illustration of the self-enhanced PDT/CDT and GSH-depletion triggered ferroptosis effect; fluorescent intensity of HCNPs in excised tumor and major healthy organs; digital images of 4T1-tumor-bearing mice at different administration time points; photographs of tumors taken from different groups of mice; H&E staining images of major organs; digital image of hemolysis; blood biochemistry analysis (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c04868/suppl_file/am1c04868_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Multifunctional metal-polyphenol nanocomposite for melanoma targeted photo/chemodynamic synergistic therapy

Ce6-modified Fe ions-doped carbon dots as multifunctional nanoplatform for ferroptosis and photodynamic synergistic therapy of melanoma

Photosensitizer-loaded Biomimetic Platform for Multimodal Imaging-Guided Synergistic Phototherapy

Synergistic Therapy for Melanoma Via Bioactive Compounds Derived Metal-Phenolic Networks

Ph/redox Dual-Stimuli-responsive Cross-Linked Polyphosphazene Nanoparticles for Multimodal Imaging-Guided Chemo-Photodynamic Therapy

Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy

Ultrasmall Ternary FePtMn Nanocrystals with Acidity‐Triggered Dual‐Ions Release and Hypoxia Relief for Multimodal Synergistic Chemodynamic/Photodynamic/Photothermal Cancer Therapy

Nanoliposomes co-encapsulating Ce6 and SB3CT against the proliferation and metastasis of melanoma with the integration of photodynamic therapy and NKG2D-related immunotherapy on A375 cells

Iron-based MOF with Catalase-like activity improves the synergistic therapeutic effect of PDT/ferroptosis/starvation therapy by reversing the tumor hypoxic microenvironment

Multifunctional CuFe2O4@HA as a GSH-depleting nanoplatform for targeted photothermal/enhanced-chemodynamic synergistic therapy

Cu2- Xs Nanocrystals Cross-Linked with Chlorin E6-Functionalized Polyethylenimine for Synergistic Photodynamic and Photothermal Therapy of Cancer.

Photosensitizer-loaded Cell Membrane Biomimetic Nanoparticles for Enhanced Tumor Synergetic Targeted Therapy

Aggregation enhanced photoactivity of photosensitizer conjugated metal nanoparticles for multimodal imaging and synergistic phototherapy below skin tolerance threshold

Metal–Organic Framework Derived Multicomponent Nanoagent as a Reactive Oxygen Species Amplifier for Enhanced Photodynamic Therapy

Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy

pH/near-infrared light dual activated Ce6-doped silicon nanoparticles with tumor chemo-photodynamic synergistic therapy for improving efficiency of monotherapy

Near-infrared light and redox dual-activatable nanosystems for synergistically cascaded cancer phototherapy with reduced skin photosensitization

H2O2-responsive polymer prodrug nanoparticles with glutathione scavenger for enhanced chemo-photodynamic synergistic cancer therapy

Self-Assembling Porphyrins as a Single Therapeutic Agent for Synergistic Cancer Therapy: A One Stone Three Birds Strategy

Co-delivery of enzymes and photosensitizers via metal-phenolic network capsules for enhanced photodynamic therapy

Enhanced Photodynamic Anticancer Activities of Multifunctional Magnetic Nanoparticles (Fe3O4) Conjugated with Chlorin e6 and Folic Acid in Prostate and Breast Cancer Cells